A nearly significant value was reported comparing the median duration of HHI treatment between locally advanced BCC patients who experienced tumor relapse (15 months [range: 7–20 months]) versus locally advanced BCC patients who did not recur (18 months [range: 1–37 months], p : 0.06).
← all excerpts
Clinical and Histological Predictors of Advanced Basal Cell Carcinoma Recurrence After Complete Response to Hedgehog Pathway Inhibitors: A Retrospective Multicenter Observational Study.
1
—
—